Battered by compounders on Makena, KV seeks bankruptcy protection
23:50 EDT 6 Aug 2012 | SCRIP
Blaming the US FDA for some its woes, KV Pharmaceuticals over the weekend revealed it had filed for Chapter 11 bankruptcy protection, hoping to get out from under its debt. KV has been struggling to make a profit from its preterm birth.....
Original Article: Battered by compounders on Makena, KV seeks bankruptcy protection
More From BioPortfolio on "Battered by compounders on Makena, KV seeks bankruptcy protection"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
